CSE bulletin 2018-1218
The common shares of Rapid Dose Therapeutics Corp. have been approved for listing on the Canadian Securities Exchange.
Listing and disclosure documents will be available on the CSE website on
the trading date.
Rapid Dose Therapeutics is a Canadian biotechnology corporation engaged in the business of developing and providing proprietary oral and non-invasive drug delivery technologies designed for applications in the nutraceutical, cannabis and pharmaceutical
businesses.
Issuer: Rapid Dose Therapeutics
Security type: common shares
Symbol: DOSE
Number of securities issued and outstanding: 75,021,327
Number of securities reserved for issuance: 8,342,132
CSE sector: life sciences
Cusip No.: 75339A 10 1
ISIN: CA 75339A 10 1 2
Board lot: 500
Trading currency: Canadian dollar
Trading date: Dec. 17, 2018
Other exchanges: not applicable
Fiscal year-end: Feb. 28
Transfer agent: Capital Transfer Agency
The exchange is accepting market-maker applications for DOSE.
© 2024 Canjex Publishing Ltd. All rights reserved.